Showing results (1-10 of 740) with videos related to

Sort By:
Pageof 74
Anticancer Research|March 23, 2002
Matrix metalloproteinases and cancerG Cox, K J O'Byrne
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancerG Cox, J L Jones, K J O'Byrne
British Journal of Cancer|September 15, 2004
Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancerD E B Swinson, G Cox, K J O'Byrne
International Journal of Cancer|April 17, 2001
Herceptest: HER2 expression and gene amplification in non-small cell lung cancerG Cox, M Vyberg, B Melgaard, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2000
Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancerG Cox, R A Walker, A Andi, et al.
Thorax|June 20, 2001
A biological staging model for operable non-small cell lung cancerG Cox, J L Jones, A Andi, et al.
Lung Cancer (Amsterdam, Netherlands)|November 21, 2001
Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancerG Cox, J Louise Jones, A Andi, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2000
Angiogenesis and non-small cell lung cancerG Cox, J L Jones, R A Walker, et al.
Pathology Oncology Research : POR|August 11, 2000
Does immunointensity account for the differences in prognostic significance of Bcl-2 expression in non-small cell lung cancer?G Cox, R A Walker, S Muller, et al.
Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Cyclooxygenase-2 protein levels are independent of epidermal growth factor receptor expression or activation in operable non-small cell lung cancerC M Richardson, D Richardson, D E B Swinson, et al.
Pageof 74